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Okadaic acid increased in parallel with carnitine palmitoyltransferase I activity and the rate of palmitate oxidation in isolated rat hepatocytes. 
Nevertheless, okadaic acid had no significant effect on the rate of octanoate oxidation. Maximal effects of okadaic acid were similar and non-additive 
to those of dibutyryl-cAMP, forskolin and glucagon. Results indicate that carnitine palmitoyltransferase I activity may be controlled by a 
mechanism of phosphorylation/dephosphorylation. 
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1. INTRODUCTION 
Carnitine palmitoyltransferase I (CPT-I), the outer 
form of carnitine palmitoyltransferase (CPT), plays a 
key role in controlling the rate of long-chain fatty acid 
oxidation in the liver [l-3]. Together with a carni- 
tine:acylcarnitine translocase and the inner form of 
CPT, carnitine palmitoyltransferase II (CPT-II), CPT-I 
mediates the entry of long-chain fatty acids into mito- 
chondrial oxidative metabolism [l-3]. Both the kinetic 
and the regulatory properties of CPT-I change with the 
nutritional and hormonal status of the animal [l-4]. 
However, the molecular bases underlaying these altera- 
tions of the CPT-I enzyme are still a matter of con- 
troversy [3,5-71. 
Short-term adaptive changes of hepatic CPT-I have 
thus far not received as much attention as long-term 
adaptive changes. This may be due to the fact that 
short-term modulation of CPT-I activity is difficult to 
preserve during the procedure of cell disruption and 
isolation of mitochondria for enzyme assay, This prob- 
lem may be circumvented by assaying CPT-I activity in 
a permeabilized-cell system [8], The use of this procedu- 
re has shown that rat liver CPT-I is regulated on the 
short term by different types of agonists, including some 
which are putative modulators of the phosphorylation 
state of the enzyme [8,9]. These observations thus sug- 
gest that a mechanism of phosphorylation-dephos- 
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phorylation might be involved in the control of hepatic 
CPT-I activity. In fact, Harano et al. [IO] have observed 
that glucagon increases both the activity and the phos- 
phorylation state of CPT in short-term hepatocyte in- 
cubations. Nevertheless, these authors only determined 
the activity of the total CPT system. In addition, their 
69-kDa immunoprecipitated CPT protein is now 
believed to be the CR-11 enzyme (see e.g. [7,11,12]). 
Very recently, an extremely useful probe for the study 
of protein phosphorylation in intact cells has become 
available. This is okadaic acid, a powerful and specific 
inhibitor of protein phosphatases 1 and 2A [13,14], 
which are the major protein phosphatases acting on 
many phosphoproteins in vivo [13-l 53. Enzymes whose 
phosphorylation state is increased in hepatocytes after 
cell incubation with okadaic acid include the rate-limit- 
ing enzymes of glycogen synthesis and degradation 
glycolysis, gluconeogenesis and fatty acid synthesis 
il3,14]. I n other tissues, okadaic acid affects a great 
number of metabolic processes which may thus be 
supposed to be controlled by a mechanism of phospho- 
rylation-dephosphorylation [ 14,16-181. Therefore, in 
the present study we examined the effects of okadaic 
acid on hepatic CPT-I activity and fatty acid oxidation. 
2. MATERIALS AI .LTHODS 
2, I. Ifqmlacyfc iwhtioti utw Ziort 
Malt Wistar rats (225-275 g) wcrc used throughout this study. 
Hepatocytcs from the whole liver were isolated as dcscribcd in [19], 
whcrcas pcriportal and perivcnous hcpatocytcs were isolated by the 
method of Chcn and Katz [20] and further charactcrizcd on tttc basis 
of the distribution pattern of several marker enzymes [21]. Hcpa- 
tocytcs wcrc incubated in Krcbs~.~Hcnselcit bicarbonate buffer supplc- 
mented with IO mM glucose and 2% (w/v) &fatted and dialyscd 
bovine strum albumin as dcscribcd bcforc [2l]. 
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2.2. Rates oJfatty acid oxidmion 
In order to monitor rates of patmitate and octanoate oxidation, 
hepatocytes were preincubated for 20 min in the presence of the addi- 
tions indicated. Then, reactions were started by the addition of 0.4 
mM albumin- bound [I-‘4C]fatty acid (either patmitate or octanoatc, 
0.5 G/mot) and carried on for 20 min. Reactions were stopped with 
0.5 ml of 2 M perchtoric acid and oxidation products were quantified 
as described before [tt]. Results show the rates of fatty acid oxidation 
to total oxidation products, which were calculated as the sum of 
acid-soluble products plus CO?. Acid-soluble products, which mainly 
represent ketone bodies, routincty accounted for more than 85% of 
total oxidation products (results not shown). 
2.3. UT-I ussay 
GPT-I activity was determined in digitonin-permeabitized hepato- 
cytes as described in ($1. The final assay mixture contained 12.5 mM 
Tris-HCI (pH 7.4), 70 mM sucrose, 5 mM glucose, 32.5 mM KC], 12.5 
mM NaHCO,. 60 mM NaCI, 0.6 mM KH2POJ, 0.6 mM MgSO,, 1.25 
mM CaCI,, I mM EDTA, 1 mM dithioerythritot. 5O@l palmitoyl- 
CoA, 0.5 mM L-[Me-‘“Cl carnitine (I CVmol), 0.5% bovine serum 
albumin (defatted and dialysed) and 40 ,~g of digitoninfmg of cellular 
protein. Reactions were stopped by the addition of 0.4 ml of I M HCI 
and [‘4C]palmitoytcarnitine product was extracted with butan-l-01 [8]. 
Matonyl-CoA- insensitive CPT activity, representing CTP-II activity 
[3,22,23], was always substracted from the CPT activity experimen- 
tally determined. CPT-II activity always accounted for less than 15% 
of the total CPT activity experimentally determined. Okadaic acid had 
no significant effect on CPT-II activity (results not shown). 
2.4. Oflwr trtrlltods 
Acetyl-CoA carboxylase and fatty acid synthase activities were de- 
termined in a permeabilized-hepatocytc system as described before 
[21,24]. Rates of fatty acid synthesis de novo were monitored as the 
incorporation of “HZ0 into total fatty acids [24]. 
3. RESULTS AND DISCLJSSIQN 
The effects of okadaic acid on fatty acid oxidation 
and CPT-I activity were studied in short-term hepato- 
cyte incubations. As a control, we always determined in 
parallel the effects of okadaic acid on acetyl-CoA car- 
boxylase activity and on the rate of fatty acid synthesis 
de novo. In agreement with published data [13], both 
acetyl-CoA carboxylase activity and the rate of fatty 
acid synthesis de novo were strongly reduced (more 
than 85% inhibition in all experiments) after hepatocyte 
incubation with 1 ,uM okadaic acid for 20 min. In addi- 
tion, 1 pM okadaic acid had no effect on the activity of 
fatty acid synthase, an enzyme which is not believed to 
be regulated by a mechanism of phosphorylation-de- 
phosphorylation (results not shown). 
Addition of okadaic acid to the incubation medium 
increased the rate of palmitate oxidation in a dose-de- 
pendent manner, maximal effects observed with 1 PM 
okadaic acid (Fig, I). Nevertheless, okadaic acid had no 
significant effect on hepatic octanoatc oxidation (Fig. 
1). It is well established that palmitate is transported 
into mitochondria by a carnitine-dependent process, 
whereas octanoate may enter mitochondria indepcn- 
dently of carnitinc [3]. Hcncc these results suggest hat 
the target for okadaic acid action might be CPT-I, the 
key regulatory ct~ytnc in the transport of long-chain 
0 lo-% IQ“ 1O-6 
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Fig. 1. Effect of okadaic acid on pa!mitate and octanoate oxidation 
by isolated hepatocytes. Hepatocytcs were preincubated for 20 min in 
the presence of increasing concentrations of okadaic acid and then the 
rates of [I-“Clpatmitate (0) and [I-‘“Cloctanoate (0) oxidation were 
determined. Results represent the means + SD of 6 (palmitate) or 5 
(octanoate) different cell preparations with cell incubations performed 
in triplicate. Control rates of [I-W]fatty acid oxidation (in nmol of 
fatty acid into total oxidation products/h x mg protein) were 43.6i5.7 
for palmitate and 102.2t28.0 for octanoate. 
fatty acids into mitochondrial oxidative metabolism [X- 
31. 
As may be seen in Fig. 2, CPT-I activity (as measured 
in a permeabilized-cell assay) was increased after hepa- 
tocyte incubation with okadaic acid. The dose-de- 
pendence of this effect was similar to the okadaic acid- 
induced stimulation of palmitate oxidation (Fig. 1). The 
stimulation of CPT-I activity by okadaic acid was evi- 
dent both in the presence and in the absence of 10 ,uM 
malonyl-CoA in the assay, though this stimulation was 
slightly higher in the latter condition (Fig. 2). Okadaic 
acid thus seems to stimulate hepatic palmitate oxidation 
by enhancing CPT-I activity. A direct effect of okadaic 
acid on the CPT-I enzyme may be ruled out in view that 
enzyme activity in isolated rat-liver mitochondria ex- 
posed to 1 pM okadaic acid was unaffected. Similarly, 
no effect of okadaic acid on CPT-I activity was ob- 
served when directly added to the permeabilized-cell 
assay instead of being added to the cell preincubation 
(results not shown). In addition, the effects of okadaic 
acid on CPT-I activity and palmitate oxidation were not 
significantly different between periportal and peri- 
venous hepatocytes, supporting the notion that both 
liver zones equally respond to short-term modulators of 
intermediary metabolism (see [2 I]), 
Since CPT-I activity was determined as the hepatoccl- 
lular CPT activity which is sensitive to inhibition by 
malonyl-CoA, it might be argued that rat liver contains 
other malonyl-CoA-inhibitable carnitine acyltransfe- 
rasc activities. Thus, it has been shown that the microso- 
ma1 medium-chain carnitine acyltransferase is sensitive 
to malonyl-CoA [23]. Just like mitochondria, micro- 
somcs remain inside the permcabilizcd cells (cf, [24]). 
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Fig. 2. Effect of okadaic acid on CPT-I activity in permeabilized 
hepatocytes. Hepatocytes were preincubated for 20 min in the prcs- 
cnce of increasing soncentrations of okadaic acid and then CPT-I 
activity was determined in permeabilized cells either in the absence (0) 
) of 10 _uM malonyl-CoA in the assay. Results 
represent the means t SD of 6 different cell preparations with cell 
incubations and enzyme assays performed in triplicate. Control values 
of CPT-I activity (in nmol of palmitoylcarnitine/min x mg protein) 
were 5.48aO.76 and 1.87kO.44 for assays performed in the absence and 
in the presence of 10 PM malonyl-CoA respectively. 
However, this enzyme activity should be strongly in- 
hibited at the concentrations of palmitoyl-CoA used in 
our assay [23]. In addition, CPT activity in peroxisomes 
is also sensitive to malonyl-CoA and may account for 
up to 20% of total CPT activity in livers from fed rats 
[22]. Peroxisomes also remain inside the permeabilized 
cells. (cf. [24]), and in this case the substrate specificity 
of peroxisomal CPT seems to be very similar to that of 
mitochondrial CPT-I [22]. Thus, we are aware that ma- 
lonyl-CoA-sensitive CPT activity in permeabilized cells 
mostly (though not exactly) represents CPT-I activity. 
It is well-established that the effects of okadaic acid on 
cellular metabolism are mediated by the inhibition of 
protein phosphatases 1 and 2A and thus by an increase 
in the phosphorylation state of target enzymes [13,14], 
In order to ascertain whether CPT-1 activity may be 
subjected to control by a mechanism of phosphoryla- 
tion-dephosphorylation, we next studied the effects of 
other cell agonists which are supposed to increase the 
phosphorylation state of the enzyme. Similarly to oka- 
daic acid. agents such as dibutyryl-CAMP, forskolin and 
glucagon stimulated palmitatc oxidation as well as 
CPT-I activity (Table I). III all cases, variations in en- 
zyme activity were paralleled by changes in the rate of 
palmitate oxidation, whereas no significant effect was 
evident 011 octanoate oxidation (Table 1). Data shown 
in Table I rcprcscnt maximal effects OT the different ~~11 
agonists under study. It is noteworthy that these maxi- 
ml effects cxcrtcd on CPT-1 activity or palmitate oxi- 
dation wc?rc in all cases (i) quantitatively similar und (ii) 
non”additive, suggesting a co1nt11o11 modification of the 
CPT-I e~~zyme. 
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Table I 
Effects of okadaic acid, di.butyryl-CAMP, forskolin and glucagon on 
hepatic fatty acid oxidation and CPT-I activity. 
Percentage of incubations with no 
additions 
-_-. 
Additions CPT-I Palmitate oxi- Octanoatc 
activity dation(rr=g) oxidation 
(n=8) (n=6) 
1 ,uuM okadaic acid 134.624.7” 135.4?~5.2” 104.3%2.6 
SO ,vM dibutyryl-CAMP 331.3+2X’ 136.5t3.2’ 107.4k4.3 
50 PM forskolin 137.8f5.3X 14O.lC4.9” 106.6t-5.2 
20 nM glucagon 127.7k7.0” 133 555 1;’ 
1 PM okadaic acid 135 1t3 9;’ . . I34:3+4:3” 
108.3-+5.7 
106.9?13.5 
+ 50 ,uM dibutyryl- 
CAMP 
I PM okadaic acid 140.4C5.5” 139.7~0~2.6” 107..5+5.2 
+ 50 ,uM forskolin 
1 ,uM okadaic acid I 32 9t4 18 . . 135.8k3.3” 107.45-4.3 
+ 20 nM glucagon 
Hepatocytes were preincubated in the presence of the additions indi- 
cated. After 20 min, part of the cells were used for measurement of 
CPT-I activity. The rest of the cells were used for determination of the 
rate of [I-‘“Clpalmitate and [I-%]octanoate oxidation. Results reprc- 
sent the means + SD of the number of cell preparations indicated in 
every case. Cell incubations and enzyme assays were always performed 
in triplicate. As dctcrmined by the Student’s f-test: “significantly differ- 
ent (PcO.01) from incubations with no additions. 
Taken together, all these data support the notion that 
enhanced phosphorylation of CPT-I may lead to a sti- 
mulation of enzyme activity and, in turn, to an activa- 
tion of palmitate oxidation. In addition, our results in- 
dicate that CPT-I seems to be a key regulatory enzyme 
in the control of the hepatic fatty-acid-oxidative pro- 
cess, at least in the experimental system presented 
herein. 
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